Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma

Completed · Phase 1/Phase 2

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients who have stage IV or recurrent melanoma.

Key facts

Study ID

NCT00012064

Run by

Lisata Therapeutics, Inc.

People needed

56

Starts

2000-07-01

Expected to finish

2011-04-01

Last updated by the study team

2014-01-29

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Hoag Cancer Center at Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.